chr19-41353016-G-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_000660.7(TGFB1):​c.29C>G​(p.Pro10Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000988 in 1,528,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P10L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 1 hom. )

Consequence

TGFB1
NM_000660.7 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.760

Publications

1023 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle and membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03548616).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000789 (12/152060) while in subpopulation SAS AF = 0.00249 (12/4826). AF 95% confidence interval is 0.00143. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000660.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB1
NM_000660.7
MANE Select
c.29C>Gp.Pro10Arg
missense
Exon 1 of 7NP_000651.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB1
ENST00000221930.6
TSL:1 MANE Select
c.29C>Gp.Pro10Arg
missense
Exon 1 of 7ENSP00000221930.4
TMEM91
ENST00000539627.5
TSL:1
c.-30+1814G>C
intron
N/AENSP00000441900.1
TGFB1
ENST00000890114.1
c.29C>Gp.Pro10Arg
missense
Exon 1 of 7ENSP00000560173.1

Frequencies

GnomAD3 genomes
AF:
0.0000790
AC:
12
AN:
151942
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000239
AC:
31
AN:
129938
AF XY:
0.000339
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000101
AC:
139
AN:
1376108
Hom.:
1
Cov.:
55
AF XY:
0.000150
AC XY:
102
AN XY:
678550
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31094
American (AMR)
AF:
0.00
AC:
0
AN:
35238
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24984
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35370
South Asian (SAS)
AF:
0.00164
AC:
129
AN:
78748
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35212
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5646
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1072406
Other (OTH)
AF:
0.000157
AC:
9
AN:
57410
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152060
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41508
American (AMR)
AF:
0.00
AC:
0
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5114
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67918
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2560
ExAC
AF:
0.000159
AC:
9

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Cystic fibrosis;C0011989:Diaphyseal dysplasia;C4748708:Inflammatory bowel disease, immunodeficiency, and encephalopathy (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
20
DANN
Benign
0.87
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.18
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.76
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.030
Sift
Benign
0.11
T
Sift4G
Benign
0.33
T
Vest4
0.23
MutPred
0.43
Gain of helix (P = 0.0078)
MVP
0.21
MPC
0.70
ClinPred
0.041
T
GERP RS
1.4
PromoterAI
-0.032
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800470; hg19: chr19-41858921; API